NVO at a glance
- As of June 30, 2026, 39 institutional investment managers tracked by SignalX reported holding Novo Nordisk A/S (NVO) shares worth $4.6 billion in 13F-HR filings.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 39 funds
- $4.6B · +1 vs prior quarter
SignalX for NVO
Don't miss the next NVO filing
- Alerts as it files. A push when NVO files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut NVO, by share count.
- Ask anything. An AI agent that reads every NVO filing and answers with sources.
NVO alerts on your phone. Follow it in the SignalX Android app.
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate NVO share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 39 | $4.64B |
| Q1 2026 | 38 | $3.76B |
| Q4 2025 | 41 | $6.98B |
| Q3 2025 | 42 | $7.78B |
| Q2 2025 | 42 | $7.34B |
| Q1 2025 | 39 | $6.70B |
| Q4 2024 | 37 | $4.83B |
| Q3 2024 | 37 | $4.29B |
- Goldman Sachs Group+4.06M (+79%)
- Wells Fargo & Co+1.02M (+28%)
- FMR LLC (Fidelity)+953.8K (+71%)
- BlackRock+909.8K (+31%)
- Morgan Stanley+790.7K (+7%)
- Two Sigma Investments−6.27M (-100%)
- Franklin Resources−3.04M (-19%)
- Citadel Advisors LLC−1.37M (-50%)
- D.E. Shaw & Co−1.34M (-66%)
- JPMorgan Chase & Co−1.20M (-43%)
Source: 13F-HR filings on SEC EDGAR (aggregated from 315 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
Related Health Care companies
- AARD · Aardvark Therapeutics, Inc.Pharmaceutical Preparations
- ABT · Abbott LaboratoriesPharmaceutical Preparations
- ABBV · AbbVie IncPharmaceutical Preparations
- ABEO · ABEONA THERAPEUTICS INC.Pharmaceutical Preparations
- ACAD · ACADIA PHARMACEUTICALS INCPharmaceutical Preparations
- ACRS · Aclaris Therapeutics, Inc.Pharmaceutical Preparations
- ACTU · ACTUATE THERAPEUTICS, INC.Pharmaceutical Preparations
- ADCT · ADC Therapeutics SAPharmaceutical Preparations
NVO SEC filings: frequently asked questions
Which institutions hold NVO stock?
As of June 30, 2026, the largest Novo Nordisk A/S (NVO) holders among the 13F filers tracked by SignalX were Franklin Resources ($625.2 million), T. Rowe Price Group ($561.1 million), Morgan Stanley ($559.0 million), Bank of America Corp ($535.8 million), Goldman Sachs Group ($440.1 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What is NVO's SEC CIK number?
Novo Nordisk A/S (NVO)'s SEC Central Index Key (CIK) is 353278. EDGAR lists every NVO filing under that number.
Ask anything about NVO
The research agent reads NVO's filings, financials, insider trades and 13F holders, then answers with sources.